NCT06481332View on ClinicalTrials.gov

"Diagnostic Characterization and Evolution of Triple Negative Thrombocytosis (CASTETTE)"

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Myeloproliferative Neoplasm
Trial Locations (1)

29609

Chu Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT06481332 - "Diagnostic Characterization and Evolution of Triple Negative Thrombocytosis (CASTETTE)" | Biotech Hunter | Biotech Hunter